Response to Comment on “Feasibility of Raman spectroscopy as a potential in vivo tool to screen for pre-diabetes and diabetes”
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
This letter aims to reply to Bratchenko and Bratchenko%27s comment on our paper “Feasibility of Raman spectroscopy as a potential in vivo tool to screen for pre-diabetes and diabetes.” Our paper analyzed the feasibility of using in vivo Raman measurements combined with machine learning techniques to screen diabetic and prediabetic patients. We argued that this approach yields high overall accuracy (94.3%25) while retaining a good capacity to distinguish between diabetic (area under the receiver-operating curve [AUC] = 0.86) and control classes (AUC = 0.97) and a moderate performance for the prediabetic class (AUC = 0.76). Bratchenko and Bratchenko%27s comment focuses on the possible overestimation of the proposed classification models and the absence of information on the age of participants. In this reply, we address their main concerns regarding our previous manuscript. © 2022 Wiley-VCH GmbH.
publication date
funding provided via
published in
Research
keywords
-
diabetes; machine learning; principal component analysis; Raman spectroscopy; support vector machine
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue